News

Today, Alzheimer’s is one of the most prevalent diseases in America, affecting about 11.3% of all people aged 65 years and over. In 2021, there were about 6.2 million people with Alzheimer’s, with the number expected to more than double and reach 13 million by 2050 should a cure not be found. It typically affects the seniors, with 72% of the 6.2 million people living with Alzheimer’s being over 75 years old.

Alzheimer’s disease affects millions of people around the world, and it is necessary to recognize it as early as possible. While people try to avoid the discomfort of current invasive methods and tests, it is essential to find less invasive methods.

People suffering from Alzheimer’s disease and other forms of dementia are among the most affected groups of individuals. Mentally and physically, they may have to face new challenges every day that sap their energy and leave them confused, lonely, and with a higher risk of depression.

While some Alzheimer’s disease myths are naive, others can lead to a poor understanding of the disease. The most dangerous are the ones that lead to a poor approach in dealing with an Alzheimer’s diagnosis

Alzheimer’s disease is one of the most difficult diseases to understand and develop new treatments for. Clinical trials for Alzheimer’s are expensive and lengthy and even when funding exists, it can be hard to find participants for them in time to optimize testing results. Also, because they have a traditionally high failure rate, they generate reticence, hesitation, and bias.

Being physically active, exercising your brain, and eating a healthy diet is currently your best bet against developing Alzheimer’s and other dementias. In this post, we’ll explore these important lifestyle factors and other healthy choices that are most often associated with preventing Alzheimer’s. Let’s get right on to it.

By continuing to explore potential treatments with different targets, as opposed to focusing exclusively on beta-amyloid proteins, researchers stand a better chance to find effective treatments for Alzheimer’s. As the Alzheimer’s Association claims on their website, “The first survivor of Alzheimer’s is out there.”

With a global societal cost of over $1 trillion annually, Alzheimer’s is one of the world’s most expensive diseases. Put another way, if Alzheimer’s were a corporation, its costs would be more than the combined profit of the 10 largest corporations in the US today.